Nautilus Biotechnology, Inc. (NAUT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 98.83M | 105.96M | 134.32M | 150.72M | 141.6M | 132.83M | 144.21M | 170.93M | 185.09M | 176.84M | 186.79M | 166.7M |
| Cash & Short-Term Investments | 95.87M | 103.41M | 131.43M | 147.87M | 138.81M | 129.89M | 140.61M | 167.44M | 181.37M | 173.42M | 183.29M | 163.29M |
| Cash Only | 14.63M | 12.39M | 23.88M | 34.46M | 33.24M | 27.65M | 4.41M | 24.89M | 25.73M | 19.4M | 74.1M | 72.14M |
| Short-Term Investments | 81.24M | 91.02M | 107.55M | 113.42M | 105.57M | 102.25M | 136.2M | 142.56M | 155.64M | 154.02M | 109.19M | 91.16M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.96M | 2.56M | 2.9M | 2.85M | 2.79M | 2.93M | 0 | 0 | 0 | 3.42M | 0 | 3.41M |
| Total Non-Current Assets | 78.95M | 85.15M | 66.59M | 62.46M | 86.09M | 109.92M | 115.5M | 101.81M | 103.56M | 128.73M | 131.55M | 164.06M |
| Property, Plant & Equipment | 30.27M | 31.23M | 28.35M | 29.65M | 30.89M | 32.33M | 33.7M | 35.17M | 36.08M | 36.9M | 37.95M | 38.86M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 47.51M | 52.74M | 37.06M | 31.64M | 54.02M | 76.41M | 80.62M | 65.47M | 66.29M | 90.65M | 92.44M | 123.43M |
| Other Non-Current Assets | 1.18M | 1.18M | 1.18M | 1.18M | 1.18M | 1.18M | 1.18M | 1.18M | 1.18M | 1.18M | 1.16M | 1.77M |
| Total Assets | 177.78M | 191.11M | 200.91M | 213.19M | 227.69M | 242.74M | 259.7M | 272.75M | 288.65M | 305.56M | 318.34M | 330.77M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -21.92% | -21.27% | -22.64% | -21.84% | -21.12% | -20.56% | -18.42% | -17.54% | -16.55% | -12.71% | -11.4% | -11.01% |
| Total Current Liabilities | 8.34M | 7.95M | 8.98M | 8.14M | 8.16M | 7.63M | 8.66M | 8.68M | 9.21M | 9.12M | 8.89M | 7.89M |
| Accounts Payable | 1.19M | 943K | 893K | 974K | 841K | 987K | 1.49M | 1.63M | 1.86M | 1.64M | 1.14M | 1.22M |
| Days Payables Outstanding | 64.91 | 53.18 | 53.05 | 50.57 | 50.62 | 17.91 | 88.86 | 99.35 | 100.07 | 80.46 | 71.78 | 79.72 |
| Short-Term Debt | 3.85M | 3.83M | 4.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.31M | 3.18M | 3.88M | 727K | 3.07M | 1.86M | 314K | 304K | 299K | 2.97M | 249K | 2.45M |
| Current Ratio | 11.85x | 13.33x | 14.95x | 18.52x | 17.36x | 17.40x | 16.65x | 19.69x | 20.09x | 19.39x | 21.00x | 21.13x |
| Quick Ratio | 11.85x | 13.33x | 14.95x | 18.52x | 17.36x | 17.40x | 16.65x | 19.69x | 20.09x | 19.39x | 21.00x | 21.13x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 25.02M | 26.19M | 22.79M | 23.96M | 25.1M | 26.38M | 27.61M | 28.79M | 29.95M | 31.09M | 32.17M | 33.2M |
| Long-Term Debt | 25.02M | 26.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 22.79M | 23.96M | 25.1M | 26.38M | 27.61M | 28.79M | 29.95M | 31.09M | 32.17M | 33.2M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 33.36M | 34.14M | 31.78M | 32.09M | 33.26M | 34.01M | 36.27M | 37.47M | 39.16M | 40.21M | 41.06M | 41.09M |
| Total Debt | 28.87M | 30.02M | 27M | 28.18M | 29.34M | 30.48M | 31.57M | 32.6M | 33.62M | 34.63M | 35.64M | 36.46M |
| Net Debt | 14.25M | 17.63M | 3.13M | -6.27M | -3.9M | 2.83M | 27.16M | 7.72M | 7.89M | 15.23M | -38.47M | -35.68M |
| Debt / Equity | 0.20x | 0.19x | 0.16x | 0.16x | 0.15x | 0.15x | 0.14x | 0.14x | 0.13x | 0.13x | 0.13x | 0.13x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 144.41M | 156.97M | 169.14M | 181.09M | 194.44M | 208.73M | 223.43M | 235.28M | 249.49M | 265.35M | 277.27M | 289.67M |
| Equity Growth % | -25.73% | -24.8% | -24.3% | -23.03% | -22.07% | -21.34% | -19.42% | -18.78% | -17.85% | -15.74% | -14.77% | -14.19% |
| Book Value per Share | 1.14 | 1.24 | 1.34 | 1.44 | 1.56 | 1.66 | 1.78 | 1.88 | 1.99 | 2.12 | 2.22 | 2.32 |
| Total Shareholders' Equity | 144.41M | 156.97M | 169.14M | 181.09M | 194.44M | 208.73M | 223.43M | 235.28M | 249.49M | 265.35M | 277.27M | 289.67M |
| Common Stock | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 12K | 12K |
| Retained Earnings | -346.72M | -332.02M | -318.24M | -304.67M | -289.63M | -273.02M | -255.43M | -238.98M | -220.97M | -202.24M | -185.22M | -169.34M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -91K | 243K | 200K | 77K | 189K | 57K | 731K | -546K | -745K | -255K | -2.03M | -2.39M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |